ArticlemBio2024

Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir.

Febri Gunawan Sugiokto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.